What's New
-
2025-11-13
(13 November 2025, Hong Kong) Hosted by The Li Shu Fan Medical Foundation and HKSH Medical Group (HKSH), and organised by the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO), the 5th Annual Conference of the Asia-Oceania Particle Therapy Co-operative Group (PTCOG-AO 2025 Conference) was successfully held from 7 to 9 November 2025. Marking the first-ever landmark... -
2025-10-30
(30 October 2025, Hong Kong) HKSH Medical Group (HKSH), having installed Asia’s first PhotonCounting Computed Tomography Simulator (PCCT-Sim) in August 2025, signed a Memorandum of Understanding (MOU) with Siemens Healthineers, the world’s first innovator of photon-counting technology, at a ceremony held on 21 October 2025. This collaboration represents a shared vision to... -
2025-10-23
(23 October 2025, Hong Kong) HKSH Medical Group (HKSH) is proud to announce the world’s first clinical study on stereotactic total ablative radiotherapy (STAR) with an MR-guided linear accelerator (MR-LINAC) for oligometastatic prostate cancer (OMPC). This study involved patients with advanced metastatic prostate cancer, utilising real-time motion tracking and precise image-... -
2025-10-21
(21 October 2025, Hong Kong) HKSH Medical Group (HKSH) introduced Hong Kong’s only and the Greater Bay Area’s first proton therapy system in 2023, after two decades of planning and preparation. Now that the HKSH Proton Therapy Centre has been in operation for two years, following the “Proton Therapy Joint Training Course” coorganised with the National Cancer Center in Beijing...
